Our Technology
- - - Our Technology
    - Learn more about our innovative technology.
  - - EyeLief®
    - Find out more about our biodegradable, preformed implant.
  - - OcuLief®
    - Find out more about our biodegradable, in situ forming implant.
Pipeline
The Team
- - - Re-Vana Team
    - Meet our researchers and management team members.
  - - Board of Directors
    - Meet our Board of Directors.
  - - Advisory Board
    - Meet our Scientific Advisory Board.
  - - Careers
Partnerships
Contact
News

News

Re-Vana, Boehringer Strike Deal for Gentler Eye-Disease Treatments

Jul 31, 2025

Excerpt from Wall Street Journal VC Daily Re-Vana, Boehringer Strike Deal for Gentler Eye-Disease Treatments By Brian Gormley, WSJ Pro Good day. Eye injections are a fact of life for many patients with severe ocular diseases. In a new partnership, Re-Vana...

Queen’s spin-out secures landmark $1bn pharma deal placing Northern Ireland on global stage

Jul 28, 2025

The partnership strengthens the University’s reputation as a leading UK university for commercialisation of research and nurturing spin-outs capable of global impact. A spin-out from Queen's University – Re-Vana Therapeutics – has signed a major collaboration deal...